Buy Revance Therapeutics Stock | RVNC Stock Price & Latest News | Public.com
RVNC

Revance Therapeutics

$0.00 (0.00%)Today
    View Revance Therapeutics (RVNC) stock trends here

    About RVNC

    Revance Therapeutics, Inc. is a clinical stage biotechnology company. It engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulin...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.45
    -0.9
    -1.34
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.04

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,81B
    Volume5
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$34.62
    1 Year Low$11.78
    Open$25.56
    High$26.73
    Low$24.94

    Buy any stock with any amount of money.

    Download the App
    Download the app